Cargando…

The curse of angiopoietin-2 in ARDS: on stranger TI(E)des

Pulmonary inflammation and vascular leakage are hallmarks of acute respiratory distress syndrome (ARDS), a life-threatening condition, for which there is no specific pharmacologic treatment. Recent literature suggests that leaky vessels in pulmonary infection and ARDS may be mediated through dysregu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kümpers, Philipp, Lukasz, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389145/
https://www.ncbi.nlm.nih.gov/pubmed/29477144
http://dx.doi.org/10.1186/s13054-018-1978-0
_version_ 1783397897086173184
author Kümpers, Philipp
Lukasz, Alexander
author_facet Kümpers, Philipp
Lukasz, Alexander
author_sort Kümpers, Philipp
collection PubMed
description Pulmonary inflammation and vascular leakage are hallmarks of acute respiratory distress syndrome (ARDS), a life-threatening condition, for which there is no specific pharmacologic treatment. Recent literature suggests that leaky vessels in pulmonary infection and ARDS may be mediated through dysregulation of a non-redundant endothelial control pathway, the Tie2 receptor and its ligands, the angiopoietins. This Viewpoint summarizes results from cell-based experiments, animal models and clinical studies underlining the potential of Tie2 targeted interventions in reducing infection-mediated pulmonary hyperpermeability.
format Online
Article
Text
id pubmed-6389145
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63891452019-03-19 The curse of angiopoietin-2 in ARDS: on stranger TI(E)des Kümpers, Philipp Lukasz, Alexander Crit Care Viewpoint Pulmonary inflammation and vascular leakage are hallmarks of acute respiratory distress syndrome (ARDS), a life-threatening condition, for which there is no specific pharmacologic treatment. Recent literature suggests that leaky vessels in pulmonary infection and ARDS may be mediated through dysregulation of a non-redundant endothelial control pathway, the Tie2 receptor and its ligands, the angiopoietins. This Viewpoint summarizes results from cell-based experiments, animal models and clinical studies underlining the potential of Tie2 targeted interventions in reducing infection-mediated pulmonary hyperpermeability. BioMed Central 2018-02-25 /pmc/articles/PMC6389145/ /pubmed/29477144 http://dx.doi.org/10.1186/s13054-018-1978-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Viewpoint
Kümpers, Philipp
Lukasz, Alexander
The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title_full The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title_fullStr The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title_full_unstemmed The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title_short The curse of angiopoietin-2 in ARDS: on stranger TI(E)des
title_sort curse of angiopoietin-2 in ards: on stranger ti(e)des
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389145/
https://www.ncbi.nlm.nih.gov/pubmed/29477144
http://dx.doi.org/10.1186/s13054-018-1978-0
work_keys_str_mv AT kumpersphilipp thecurseofangiopoietin2inardsonstrangertiedes
AT lukaszalexander thecurseofangiopoietin2inardsonstrangertiedes
AT kumpersphilipp curseofangiopoietin2inardsonstrangertiedes
AT lukaszalexander curseofangiopoietin2inardsonstrangertiedes